K22.719 Barrett's esophagus with dysplasia, unspecified

Name of the Condition

• Barrett's esophagus with dysplasia, unspecified

Summary

Barrett's esophagus with dysplasia, unspecified, is a precancerous condition where the normal lining of the esophagus is replaced by intestinal-type tissue (intestinal metaplasia) and shows abnormal cellular changes (dysplasia). This condition is associated with chronic gastroesophageal reflux disease (GERD) and increases the risk of developing esophageal adenocarcinoma. Diagnosis typically involves endoscopic evaluation with biopsy to assess dysplasia grade.

Causes

The primary cause is chronic exposure of the esophageal lining to stomach acid and bile, most commonly due to GERD. Long-term acid reflux damages the esophageal epithelium, leading to intestinal metaplasia. Dysplasia arises when these abnormal cells undergo further genetic changes, often driven by persistent inflammation and acid exposure.

Risk Factors

• Chronic gastroesophageal reflux disease (GERD)
• Obesity, particularly abdominal obesity
• Male gender
• Age (more common in adults over 50)
• Tobacco use
• Family history of Barrett's esophagus or esophageal cancer

Symptoms

• Chronic heartburn or acid reflux
• Difficulty swallowing (dysphagia)
• Chest pain unrelated to heartburn
• Regurgitation of food or liquid
• Unexplained weight loss (in advanced cases)

Diagnosis

Diagnosis requires an upper endoscopy with targeted biopsies to assess dysplasia grade. The procedure allows visualization of the esophageal lining and collection of tissue samples for histopathological examination. Biopsies are critical to confirm the presence and severity of dysplasia, which guides management decisions.

Treatment Options

Treatment focuses on managing GERD and addressing dysplasia. Options may include proton pump inhibitors (PPIs) to reduce acid production, endoscopic therapies (e.g., radiofrequency ablation, endoscopic mucosal resection) for dysplasia, and surveillance endoscopies. In severe cases, surgery may be considered.

Prognosis and Follow-Up

Prognosis depends on the grade of dysplasia and response to treatment. Unspecified dysplasia requires regular endoscopic surveillance to monitor for progression. Early detection and intervention improve outcomes, while advanced dysplasia increases cancer risk. Follow-up intervals are determined by dysplasia severity and treatment response.

Complications

• Esophageal adenocarcinoma (if dysplasia progresses)
• Stricture formation (narrowing of the esophagus)
• Bleeding from esophageal lesions
• Persistent reflux symptoms despite treatment

Lifestyle & Prevention

• Manage GERD with lifestyle modifications (e.g., diet changes, weight loss)
• Avoid tobacco and excessive alcohol use
• Elevate the head of the bed to reduce reflux
• Maintain a healthy weight
• Follow prescribed acid-suppressing medications as directed

When to Seek Professional Help

Seek medical attention if you experience persistent heartburn, difficulty swallowing, unexplained weight loss, or chest pain. These symptoms may indicate worsening dysplasia or complications requiring prompt evaluation.

Tips for Medical Coders

Document the presence of Barrett's esophagus with dysplasia, unspecified, and specify the endoscopic findings and biopsy results. Ensure clinical documentation supports the diagnosis and any associated GERD or complications. Note that this code is used when dysplasia grade is not further specified.